查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1463082

蛇抗毒素市场,占有率,规模,趋势,产业分析报告:依类型、作用机制、最终用户、地区、细分市场预测，2024-2032

Snake Antivenom Market Share, Size, Trends, Industry Analysis Report, By Type (Polyvalent Heterologous, Monovalent Heterologous, Homologous, and Small Molecule Anti-Toxins); By Mode of Action; By End User; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 119 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research最新研究显示，到2032年，全球蛇抗蛇毒血清市场规模预计将达到6.3685亿美元。该报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

蛇咬伤作为各地区常见的公共卫生问题，其发病率不断上升，增加了对有效的毒液中和解决方案和治疗方法的需求，推动了市场的成长。医疗保健专业人员对蛇咬伤的识别、管理和治疗的认识正在推动抗蛇毒血清药物的需求。此外，研究和开发的进步促使开发出更有效的抗蛇毒血清製剂以及诊断和治疗方法的进步预计将进一步推动市场成长。

例如，2023年1月，Ophirex Inc.宣布完成3,700万美元B轮融资。这笔资金将用于继续临床开发和监管提交，以推进广泛的蛇咬伤治疗。

提供有效、安全和高品质的特有物种专用产品已成为减少蛇咬伤负担的重要因素。从国家层级来看，抗蛇毒血清产量不足以满足临床需求，尤其是抗蛇毒血清生产不良的地区。因此，增强抗蛇毒血清生产或开发能力的新机会正在出现，这也是市场成长的好兆头。

例如，《Indian Journal of Medical Research》2023 年 4 月发表的一份报告发现，印度致力于制定一项国家蛇咬伤预防和控制计划，并鼓励开发新型有效的抗蛇毒血清。

此外，人们越来越关注蛇抗蛇毒血清领域的研究和开发活动，其中主要包括开发新的和改进的治疗製剂以及改善整体治疗结果等活动。这将有助于患者迅速从疼痛中恢復，并减少世界各地不断增加的蛇咬伤死亡人数。

蛇抗蛇毒血清市场报告亮点

多价异质药物部分占最大占有率。

由于神经毒性蛇咬伤的盛行率不断上升以及医疗保健专业人员的采用，神经毒性部分占据了最大占有率。

由于患者人数大幅增加和医院基础设施的改善，医院和诊所部门将以最快的速度成长。

由于蛇咬伤事件数量不断增加，死亡人数不断增加，预计亚太地区将主导全球市场。

主要市场参与者包括Boehringer Ingelheim Thermo Fisher, Hamilton Company, Incepta vaccine, Novo Nordisk, rare disease treatment, Bioclon。

目录

第一章简介

第二章执行摘要

第三章研究方法论

第四章全球蛇抗蛇毒血清市场洞察

  • 蛇抗蛇毒血清市场 – 最终用户快照
  • 蛇抗蛇毒血清市场动态
    • 驱动因素和机遇
      • 蛇咬伤事件增加，研发活动投资增加
      • 政府措施和资金
    • 限制因素和课题
      • 抗蛇毒血清生产成本高
  • PESTEL 分析
  • 蛇抗蛇毒血清市场最终用户趋势
  • 价值链分析
  • COVID-19 影响分析

第五章依类型划分的世界市场

  • 主要发现
  • 介绍
  • 多价异质
  • 单价异质
  • 相同的
  • 小分子

第六章全球市场的作用机制

  • 主要发现
  • 介绍
  • 细胞毒性
  • 神经毒性
  • 血液毒性
  • 心臟毒性
  • 肌肉毒性
  • 其他

第七章最终用户的全球市场

  • 主要发现
  • 介绍
  • 医院/诊所
  • 门诊手术中心
  • 研究机构
  • 其他

第八章依地区划分的世界市场

  • 主要发现
  • 介绍
    • 蛇抗毒素市场评估，依地区，2019-2032
  • 蛇抗蛇毒血清市场－北美
    • 北美：蛇抗蛇毒血清市场，依类型，2019-2032
    • 北美：蛇抗蛇毒血清市场，依最终用户划分，2019-2032 年
    • 北美：蛇抗毒素市场，依作用机制，2019-2032
    • 蛇抗蛇毒血清市场—美国
    • 蛇抗蛇毒血清市场—加拿大
  • 蛇抗蛇毒血清市场—欧洲
    • 欧洲：蛇抗蛇毒血清市场，依类型，2019-2032
    • 欧洲：蛇抗蛇毒血清市场，依最终用户划分，2019-2032 年
    • 欧洲：蛇抗蛇毒血清市场，依作用机制，2019-2032
    • 蛇抗蛇毒血清市场—英国
    • 蛇抗蛇毒血清市场—法国
    • 蛇抗蛇毒血清市场—德国
    • 蛇抗蛇毒血清市场—义大利
    • 蛇抗蛇毒血清市场—西班牙
    • 蛇抗蛇毒血清市场—荷兰
    • 蛇抗蛇毒血清市场—俄罗斯
  • 蛇毒血清市场 – 亚太地区
    • 亚太地区：蛇抗蛇毒血清市场，依类型，2019-2032
    • 亚太地区：蛇抗蛇毒血清市场，依最终用户划分，2019-2032 年
    • 亚太地区：蛇抗蛇毒血清市场（依作用机制），2019-2032 年
    • 蛇抗蛇毒血清市场—中国
    • 蛇抗蛇毒血清市场—印度
    • 蛇毒血清市场 – 马来西亚
    • 蛇抗蛇毒血清市场—日本
    • 蛇抗蛇毒血清市场-印度尼西亚
    • 蛇抗蛇毒血清市场－韩国
  • 蛇抗蛇毒血清市场 - 中东和非洲
    • 中东和非洲：蛇抗蛇毒血清市场，依类型，2019-2032
    • 中东和非洲：蛇抗蛇毒血清市场，依最终用户划分，2019-2032 年
    • 中东和非洲：蛇抗毒素市场，依作用机制，2019-2032
    • 蛇抗蛇毒血清市场-沙乌地阿拉伯
    • 蛇抗蛇毒血清市场 - 阿联酋
    • 蛇抗蛇毒血清市场—以色列
    • 蛇毒血清市场—南非
  • 蛇毒血清市场—拉丁美洲
    • 拉丁美洲：蛇抗蛇毒血清市场，依类型，2019-2032
    • 拉丁美洲：蛇抗蛇毒血清市场，依最终用户划分，2019-2032 年
    • 拉丁美洲：蛇抗蛇毒血清市场（依作用机制），2019-2032 年
    • 蛇抗蛇毒血清市场—墨西哥
    • 蛇抗蛇毒血清市场－巴西
    • 蛇抗蛇毒血清市场—阿根廷

第9章 竞争格局

  • 扩张和收购分析
    • 扩张
    • 收购
  • 伙伴关係/协作/协议/出版物

第十章公司简介

  • Bharat Serums and Vaccine Limited
  • Bioclon Institute
  • Boehringer-Ingelheim Thermo Fisher
  • Boston Scientific Corporation
  • BTG International Inc.
  • CSL Limited
  • Hamilton Company
  • Incepta Vaccine Ltd.
  • Inosan Biopharma
  • Merck & Co. Inc.
  • MicroPharm
  • Novo Nordisk A/S
  • Owen Mumford Ltd.
  • Pfizer Inc.
  • Rare Disease Therapeutics Inc.
  • VINS Bioproducts Limited
Product Code: PM4444

The global snake antivenom market size is expected to reach USD 636.85 Million by 2032, according to a new study by Polaris Market Research. The report "Snake Antivenom Market Share, Size, Trends, Industry Analysis Report, By Type (Polyvalent Heterologous, Monovalent Heterologous, Homologous, and Small Molecule Anti-Toxins); By Mode of Action; By End User; By Region; Segment Forecast, 2024 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rising prevalence of snakebites as a common public health issue across various regions and increased demand for effective venom neutralizing solutions or treatments, driving the market's growth. Awareness among healthcare professionals about the identification, management, and treatment of snakebites, fostering the demand for antivenoms. Additionally, growing advances in R&D that results in the creation of more effective antivenom formulations and advancements in diagnostics and treatment methods, are further anticipated to boost market's growth.

For instance, in January 2023, Ophirex Inc., announced that they completed a USD 37 million Series B financing. The funds will be used to continue clinical development and regulatory submission in order to advance broad-spectrum snakebite treatment.

The access to effective, safe, and quality products that are specially tailored to the endemic species has been becoming an important component to reduce the burden of snake bites. At the national level, there is insufficient manufacturing output of antivenoms to meet the clinical needs especially for antivenoms intended for use in region with scarcity of producers. Thus, there is an emerging opportunity for manufacturing or developing antivenoms with enhanced capabilities, which will also bode well for market's growth.

For instance, according to a report published by the Indian Journal of Medical Research in April 2023, India is focusing on a national programme for prevention & control of snakebite in India that encourages the development new and effective antivenoms.

Furthermore, there is a growing emphasis on research & development activities in the field of snake antivenom which mainly includes activities like creation of new improved treatment formulations and improving the overall treatment outcomes. It helps patients quickly recover from the pain and reduces the number of constantly rising deaths due to snakebites across the globe.

Snake Antivenom Market Report Highlights

Polyvalent heterologous segment accounted for the largest share, due to its higher effectiveness and preference over alternative options

Neurotoxic segment held the maximum share, on account of rising prevalence of neurotoxic snakebites and its adoption among healthcare professionals

Hospitals & clinics segment will grow at fastest pace, owing to significant increase in patient population and improvements in hospitals infrastructure

Asia Pacific is expected to dominated the global market, due to rising incidences of snakebites and number of deaths occurs due to thus in the region

The key market players include Boehringer-Ingelheim Thermo Fisher, Hamilton Company, Incepta Vaccine, Novo Nordisk, Rare Disease Therapeutics, and Bioclon

Polaris Market Research has segmented the snake antivenom market report based on type, mode of action, end user, and region:

Snake Antivenom, Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Polyvalent Heterologous
  • Monovalent Heterologous
  • Homologous
  • Small Molecule Anti-Toxins

Snake Antivenom, Mode of Action Outlook (Revenue - USD Million, 2019 - 2032)

  • Cytotoxic
  • Neurotoxic
  • Haemotoxic
  • Cardiotoxic
  • Myotoxic
  • Others

Snake Antivenom, End User Outlook (Revenue - USD Million, 2019 - 2032)

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Research Institutes
  • Others

Snake Antivenom, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Snake Antivenom Market Insights

  • 4.1. Snake Antivenom Market - End User Snapshot
  • 4.2. Snake Antivenom Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Growing incidences of snakebites and rising investments on R&D activities spurring the global market growth.
      • 4.2.1.2. Government Initiatives and Funding.
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Costs of Antivenom Production.
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Snake Antivenom Market End User Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Snake Antivenom Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • 5.3. Polyvalent Heterologous
    • 5.3.1. Global Snake Antivenom Market, by Polyvalent Heterologous, by Region, 2019-2032 (USD Million)
  • 5.4. Monovalent Heterologous
    • 5.4.1. Global Snake Antivenom Market, by Monovalent Heterologous, by Region, 2019-2032 (USD Million)
  • 5.5. Homologous
    • 5.5.1. Global Snake Antivenom Market, by Homologous, by Region, 2019-2032 (USD Million)
  • 5.6. Small Molecule
    • 5.6.1. Global Snake Antivenom Market, by Small Molecule, by Region, 2019-2032 (USD Million)

6. Global Snake Antivenom Market, by Mode of Action

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • 6.3. Cytotoxic
    • 6.3.1. Global Snake Antivenom Market, by Cytotoxic, by Region, 2019-2032 (USD Million)
  • 6.4. Neurotoxic
    • 6.4.1. Global Snake Antivenom Market, by Neurotoxic, by Region, 2019-2032 (USD Million)
  • 6.5. Haemotoxic
    • 6.5.1. Global Snake Antivenom Market, by Haemotoxic, by Region, 2019-2032 (USD Million)
  • 6.6. Cardiotoxic
    • 6.6.1. Global Snake Antivenom Market, by Cardiotoxic, by Region, 2019-2032 (USD Million)
  • 6.7. Myotoxic
    • 6.7.1. Global Snake Antivenom Market, by Myotoxic, by Region, 2019-2032 (USD Million)
  • 6.8. Others
    • 6.8.1. Global Snake Antivenom Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Snake Antivenom Market, by End User

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • 7.3. Hospitals & Clinics
    • 7.3.1. Global Snake Antivenom Market, by Hospitals & Clinics, By Region, 2019-2032 (USD Million)
  • 7.4. Ambulatory Surgical Centers
    • 7.4.1. Global Snake Antivenom Market, by Ambulatory Surgical Centers, By Region, 2019-2032 (USD Million)
  • 7.5. Research Institutes
    • 7.5.1. Global Snake Antivenom Market, by Research Institutes, By Region, 2019-2032 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Snake Antivenom Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Snake Antivenom Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Snake Antivenom Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Snake Antivenom Market - North America
    • 8.3.1. North America: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
    • 8.3.3. North America: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.3.4. Snake Antivenom Market - U.S.
      • 8.3.4.1. U.S.: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.3.5. Snake Antivenom Market - Canada
      • 8.3.5.1. Canada: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • 8.4. Snake Antivenom Market - Europe
    • 8.4.1. Europe: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
    • 8.4.3. Europe: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.4.4. Snake Antivenom Market - UK
      • 8.4.4.1. UK: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.4.5. Snake Antivenom Market - France
      • 8.4.5.1. France: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.4.5.3. France: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.4.6. Snake Antivenom Market - Germany
      • 8.4.6.1. Germany: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.4.7. Snake Antivenom Market - Italy
      • 8.4.7.1. Italy: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.4.8. Snake Antivenom Market - Spain
      • 8.4.8.1. Spain: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.4.9. Snake Antivenom Market - Netherlands
      • 8.4.9.1. Netherlands: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.4.10. Snake Antivenom Market - Russia
      • 8.4.10.1. Russia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • 8.5. Snake Antivenom Market - Asia Pacific
    • 8.5.1. Asia Pacific: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.5.4. Snake Antivenom Market - China
      • 8.5.4.1. China: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.5.4.3. China: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.5.5. Snake Antivenom Market - India
      • 8.5.5.1. India: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.5.5.3. India: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.5.6. Snake Antivenom Market - Malaysia
      • 8.5.6.1. Malaysia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.5.7. Snake Antivenom Market - Japan
      • 8.5.7.1. Japan: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.5.8. Snake Antivenom Market - Indonesia
      • 8.5.8.1. Indonesia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.5.9. Snake Antivenom Market - South Korea
      • 8.5.9.1. South Korea: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • 8.6. Snake Antivenom Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.6.4. Snake Antivenom Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.6.5. Snake Antivenom Market - UAE
      • 8.6.5.1. UAE: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.6.6. Snake Antivenom Market - Israel
      • 8.6.6.1. Israel: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.6.7. Snake Antivenom Market - South Africa
      • 8.6.7.1. South Africa: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • 8.7. Snake Antivenom Market - Latin America
    • 8.7.1. Latin America: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.7.4. Snake Antivenom Market - Mexico
      • 8.7.4.1. Mexico: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.7.5. Snake Antivenom Market - Brazil
      • 8.7.5.1. Brazil: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
    • 8.7.6. Snake Antivenom Market - Argentina
      • 8.7.6.1. Argentina: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Bharat Serums and Vaccine Limited
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. Bioclon Institute
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Boehringer-Ingelheim Thermo Fisher
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Boston Scientific Corporation
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. BTG International Inc.
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. CSL Limited
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Hamilton Company
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Incepta Vaccine Ltd.
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Inosan Biopharma
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Merck & Co. Inc.
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. MicroPharm
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development
  • 10.12. Novo Nordisk A/S
    • 10.12.1. Company Overview
    • 10.12.2. Financial Performance
    • 10.12.3. Product Benchmarking
    • 10.12.4. Recent Development
  • 10.13. Owen Mumford Ltd.
    • 10.13.1. Company Overview
    • 10.13.2. Financial Performance
    • 10.13.3. Product Benchmarking
    • 10.13.4. Recent Development
  • 10.14. Pfizer Inc.
    • 10.14.1. Company Overview
    • 10.14.2. Financial Performance
    • 10.14.3. Product Benchmarking
    • 10.14.4. Recent Development
  • 10.15. Rare Disease Therapeutics Inc.
    • 10.15.1. Company Overview
    • 10.15.2. Financial Performance
    • 10.15.3. Product Benchmarking
    • 10.15.4. Recent Development
  • 10.16. VINS Bioproducts Limited
    • 10.16.1. Company Overview
    • 10.16.2. Financial Performance
    • 10.16.3. Product Benchmarking
    • 10.16.4. Recent Development

List of Tables

  • Table 1 Global Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 2 Global Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 3 Global Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 4 Snake Antivenom Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 6 North America: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 7 North America: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 8 U.S.: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 10 U.S.: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 11 Canada: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 12 Canada: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 13 Canada: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 14 Europe: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 15 Europe: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 16 Europe: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 17 UK: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 18 UK: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 19 UK: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 20 France: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 21 France: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 22 France: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 23 Germany: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 24 Germany: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 25 Germany: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 26 Italy: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 27 Italy: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 28 Italy: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 29 Spain: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 30 Spain: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 31 Spain: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 32 Netherlands: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 34 Netherlands: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 35 Russia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 36 Russia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 37 Russia: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 41 China: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 42 China: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 43 China: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 44 India: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 45 India: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 46 India: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 47 Malaysia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 49 Malaysia: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 50 Japan: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 51 Japan: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 52 Japan: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 53 Indonesia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 55 Indonesia: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 56 South Korea: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 58 South Korea: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 65 UAE: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 66 UAE: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 67 UAE: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 68 Israel: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 69 Israel: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 70 Israel: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 71 South Africa: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 73 South Africa: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 74 Latin America: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 76 Latin America: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 77 Mexico: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 79 Mexico: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 80 Brazil: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 82 Brazil: Snake Antivenom Market, by End User, 2019-2032 (USD Million)
  • Table 83 Argentina: Snake Antivenom Market, by Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Snake Antivenom Market, by Mode of Action, 2019-2032 (USD Million)
  • Table 85 Argentina: Snake Antivenom Market, by End User, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Snake Antivenom Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Mode of Action
  • Figure 7. Global Snake Antivenom Market, by Mode of Action, 2022 & 2032 (USD Million)
  • Figure 8. Market by Type
  • Figure 9. Global Snake Antivenom Market, by Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by End User
  • Figure 11. Global Snake Antivenom Market, by End User, 2022 & 2032 (USD Million)
  • Figure 12. Snake Antivenom Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Snake Antivenom Market